Dupilumab Reduces Exacerbations And Improves Lung Function Regardless Of Prior Asthma Exacerbation Status: LIBERTY ASTHMA TRAVERSE Open-Label Extension Study

被引：0
|
作者：
Papi, Alberto [1 ]
Castro, Mario [2 ]
Busse, William [3 ]
Korn, Stephanie [4 ,5 ]
Xia, Changming [6 ]
Soler, Xavier [6 ]
Pandit-Abid, Nami [7 ]
Radwan, Amr [6 ]
Jacob-Nara, Juby [7 ]
Rowe, Paul [7 ]
Deniz, Yamo [6 ]
机构：
[1] Univ Ferrara, S Anna Univ Hosp, Resp Med Unit, Ferrara, Italy
[2] Univ Kansas, Sch Med, Kansas City, KS USA
[3] Univ Wisconsin, UW Allergy Pulm & Crit Care Med, Sch Med & Publ Hlth, Madison, WI USA
[4] IKF Pneumol Mainz, Mainz, Germany
[5] Thoraxklin Heidelberg, Mainz, Germany
[6] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[7] Sanofi, Bridgewater, NJ USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2023年 / 151卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
597
引用
收藏
页码：AB193 / AB193
页数：1
相关论文
共 50 条
  • [1] Dupilumab efficacy is not affected by prior asthma exacerbation status in LIBERTY ASTHMA TRAVERSE open-label extension study
    Papi, A.
    Castro, M.
    Busse, W. W.
    Langton, D.
    Korn, S.
    Xia, C.
    Soler, X.
    Pandit-Abid, N.
    Amr, R.
    Jacob-Nara, J. A.
    Rowe, P. J.
    Deniz, Y.
    THORAX, 2023, 78 (SUPPL_4) : A85 - A85
  • [2] Dupilumab improves exacerbations and lung function irrespective of prior asthma exacerbations: TRAVERSE
    Papi, A.
    Castro, M.
    Busse, W. W.
    Langton, D.
    Korn, S.
    Xia, C.
    Soler, X.
    Pandit-Abid, N.
    Siddiqui, S.
    Jacob-Nara, J. A.
    Rowe, P. J.
    Deniz, Y.
    ALLERGOLOGIE, 2022, 45 (08) : 605 - 605
  • [3] Dupilumab improves exacerbations and lung function irrespective of prior asthma exacerbations: TRAVERSE
    Lommatzsch, M.
    Papi, A.
    Castro, M.
    Busse, W.
    Langton, D.
    Korn, S.
    Xia, C.
    Soler, X.
    Pandit-Abid, N.
    Siddiqui, S.
    Jacob-Nara, J.
    Rowe, P.
    Deniz, Y.
    PNEUMOLOGIE, 2023, 77 : S90 - S90
  • [4] Dupilumab improves exacerbations and lung function irrespective of prior asthma exacerbations: TRAVERSE
    Papi, A.
    Castro, M.
    Busse, W. W.
    Langton, D.
    Korn, S.
    Xia, C.
    Soler, X.
    Pandit-Abid, N.
    Siddiqui, S.
    Jacob-Nara, J. A.
    Rowe, P. J.
    Deniz, Y.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [5] DUPILUMAB REDUCES SEVERE ASTHMA EXACERBATION RATE AND IMPROVES LUNG FUNCTION REGARDLESS OF AGE AT ONSET OF ASTHMA: THE LIBERTY ASTHMA QUEST STUDY
    Castro, Mario
    Hanania, Nicola
    Quirce, Santiago
    Sher, Lawrence
    Maspero, Jorge
    Rice, Megan
    Djandji, Michel
    Ballard, Mark
    Rowe, Paul
    Deniz, Yamo
    Teper, Ariel
    CHEST, 2019, 156 (04) : 936A - 939A
  • [6] DUPILUMAB REDUCES EXACERBATIONS AND IMPROVES LUNG FUNCTION IN UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA PATIENTS REGARDLESS OF PRIOR EXACERBATION HISTORY IN THE PHASE 3 LIBERTY ASTHMA QUEST STUDY
    Pavord, I.
    Ford, L. B.
    Corren, J.
    Kuna, P.
    Dong, Q.
    Staudinger, H.
    Maroni, J.
    Rowe, P.
    Rout, R.
    Amin, N.
    Akinlade, B.
    Graham, N. M. H.
    Teper, A.
    THORAX, 2018, 73 : A121 - A122
  • [7] Dupilumab improved lung function and reduced exacerbation rates in patients with moderate-tosevere asthma and prior exacerbations: LIBERTY ASTHMA TRAVERSE study
    Rhee, Chin Kook
    Corren, Jonathan
    Castro, Mario
    Maspero, Jorge F.
    Humbert, Marc
    Halpin, David M. G.
    Altincatal, Arman
    Pandit-Abid, Nami
    Soler, Xavier
    Siddiqui, Shahid
    Jacob-Nara, Juby A.
    Deniz, Yamo
    Rowe, Paul J.
    RESPIROLOGY, 2023, 28 : 76 - 78
  • [8] LONG-TERM SAFETY AND EFFICACY OF DUPILUMAB IN PATIENTS WITH ASTHMA: LIBERTY ASTHMA TRAVERSE OPEN-LABEL EXTENSION STUDY
    Pavord, Id
    Wechsler, Me
    Domingo, C.
    Papi, A.
    Bourdin, A.
    Watz, H.
    Mao, X.
    Kapoor, U.
    Khokhar, Fa
    Mannent, Lp
    Ruddy, M.
    Laws, E.
    Amin, N.
    Hardin, M.
    THORAX, 2021, 76 : A81 - A82
  • [9] DUPILUMAB REDUCES SEVERE ASTHMA EXACERBATION RATES AND IMPROVES LUNG FUNCTION ACROSS A RANGE OF PRIOR EXACERBATIONS IN PATIENTS WITH ELEVATED TYPE 2 BIOMARKERS: THE LIBERTY ASTHMA QUEST STUDY
    Katelaris, Constance H.
    Douglass, Jo A.
    Ford, Linda B.
    Rice, Megan S.
    Moody, Jana
    Djandji, Michel
    Radwan, Amr
    Rowe, Paul
    Deniz, Yamo
    Amin, Nikhil
    Teper, Ariel
    INTERNAL MEDICINE JOURNAL, 2019, 49 : 34 - 35
  • [10] DUPILUMAB REDUCED EXACERBATIONS AND IMPROVED LUNG FUNCTIONS IN PATIENTS WITH MODERATE-TO-SEVERE ASTHMA AND PRIOR EXACERBATIONS: LIBERTY ASTHMA TRAVERSE STUDY
    Corren, Jonathan
    Castro, Mario
    Maspero, Jorge F.
    Humbert, Marc
    Halpin, David M. G.
    Altincatal, Arman
    Pandit-Abid, Nami
    Soler, Xavier
    Siddiqui, Shahid
    Jacob-Nara, Juby A.
    Deniz, Yamo
    Rowe, Paul J.
    CHEST, 2022, 162 (04) : 1936A - 1938A
12345